Form 10-Q · Quarterly report
3M 10-Q, filed Jul 21, 2026
- Filed
- CIK
- 0000066740
- Accession no.
- 0000066740-26-000246
Summary
3M reported second-quarter 2026 net sales of $6.5 billion, up 2.4% from a year earlier, with GAAP operating income margin of 15.1% and adjusted operating margin of 24.9%; GAAP diluted EPS was $1.78 versus adjusted EPS of $2.40. 3M said sales growth came from industrial, safety, semiconductor and data center markets, partly offset by weakness in consumer and consumer electronics and by the year-over-year effect of the manufactured PFAS products item, and that it completed its exit from PFAS manufacturing by the end of 2025.
Key points
- Second-quarter 2026 net sales were $6,500 million, with organic sales up 2.3%; first-half net sales were $12,530 million.
- Second-quarter GAAP EPS was $1.78, up 33% year over year, while adjusted EPS was $2.40, up 11%.
- 3M's operations are managed in three segments: Safety and Industrial, Transportation and Electronics, and Consumer.
- Second-quarter results included a loss on business divestitures equal to 5.2% of net sales, versus 0.1% a year earlier.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview 3M is a diversified global manufacturer, technology innovator and marketer of a wide variety of products and services. As discussed in Note 1, certain changes are reflective in this document for all applicable periods presented. Effective in the first and second quarters of 2026, the Company made changes to the measure of segment operating performance and segment composition used by its CODM, impacting the disclosed measure of segment profit (business segment operating income). Further details are provided in Note 16. 3M manages its operations in three operating business segments: Safety and Industrial; Transportation and Electronics; and Consumer. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.